By our pilot study, we provide evidence that SCH900776 potentiates FLU activity in currently incurable CLL and that this effect is achievable in both TP53-mutated and TP53-wt cells. The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.